Home LiteratureArticle Details
PMID: 15308692 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Influenza: emergence and control.

Journal of virology ·Vol. 78 ·No. 17 ·2004-09-00 ·Pages 8951-9

Lipatov AS, Govorkova EA, Webby RJ, Ozaki H, Peiris M, Guan Y, Poon L, Webster RG

Abstract

暂无摘要

MeSH Terms
Animals Antiviral Agents/pharmacology,therapeutic use Birds/virology Humans Influenza Vaccines Influenza, Human/drug therapy,epidemiology,prevention & control,transmission Orthomyxoviridae/drug effects,immunology,pathogenicity Swine/virology
Chemicals
Antiviral Agents Influenza Vaccines
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Lipatov Aleksandr S
Division of Virology, Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Govorkova Elena A
Webby Richard J
Ozaki Hiroichi
Peiris Malik
Guan Yi
Poon Leo
Webster Robert G
References (92)
92 references, click to expand
  1. Cocirculation of avian H9N2 and contemporary "human" H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment?
    J Virol. 2001 Oct;75(20):9679-86 PMID: 11559800
  2. Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China.
    J Virol. 2002 Jan;76(1):118-26 PMID: 11739677
  3. Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells.
    J Virol. 2002 Feb;76(3):1071-6 PMID: 11773383
  4. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus.
    Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1829-39 PMID: 11779381
  5. Developing vaccines against pandemic influenza.
    Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1953-60 PMID: 11779397
  6. H5N1 influenza: a protean pandemic threat.
    Proc Natl Acad Sci U S A. 2004 May 25;101(21):8156-61 PMID: 15148370
  7. Evidence for the natural transmission of influenza A virus from wild ducts to swine and its potential importance for man.
    Bull World Health Organ. 1981;59(1):75-8 PMID: 6973418
  8. Genetic relatedness of hemagglutinins of the H1 subtype of influenza A viruses isolated from swine and birds.
    Virology. 1983 Sep;129(2):521-3 PMID: 6623931
  9. Influenza virus A pathogenicity: the pivotal role of hemagglutinin.
    Cell. 1987 Aug 28;50(5):665-6 PMID: 3304656
  10. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics.
    J Virol. 1989 Nov;63(11):4603-8 PMID: 2795713
  11. Evolution of pig influenza viruses.
    Virology. 1991 Jul;183(1):61-73 PMID: 2053297
  12. Evolution and ecology of influenza A viruses.
    Microbiol Rev. 1992 Mar;56(1):152-79 PMID: 1579108
  13. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine.
    Curr Top Microbiol Immunol. 1992;176:119-30 PMID: 1600749
  14. Pandemic influenza: a zoonosis?
    Semin Respir Infect. 1992 Mar;7(1):11-25 PMID: 1609163
  15. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza.
    Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10736-41 PMID: 12149435
  16. Phylogenetic analysis of H1N2 isolates of influenza A virus from pigs in the United States.
    Virus Res. 2002 Aug;87(2):173-9 PMID: 12191781
  17. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses.
    Nat Med. 2002 Sep;8(9):950-4 PMID: 12195436
  18. Assessment of hemagglutinin sequence heterogeneity during influenza virus transmission in families.
    J Infect Dis. 2002 Dec 1;186(11):1575-81 PMID: 12447732
  19. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?
    Lancet. 2002 Dec 7;360(9348):1831-7 PMID: 12480361
  20. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.
    Virology. 2003 Jan 5;305(1):192-200 PMID: 12504552
  21. Role of quail in the interspecies transmission of H9 influenza A viruses: molecular changes on HA that correspond to adaptation from ducks to chickens.
    J Virol. 2003 Mar;77(5):3148-56 PMID: 12584339
  22. Neurovirulence in mice of H5N1 influenza virus genotypes isolated from Hong Kong poultry in 2001.
    J Virol. 2003 Mar;77(6):3816-23 PMID: 12610156
  23. Novel generations of influenza vaccines.
    Vaccine. 2003 May 1;21(16):1789-95 PMID: 12686096
  24. Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein.
    Virology. 2003 May 10;309(2):181-9 PMID: 12758165
  25. Replication and transmission of influenza viruses in Japanese quail.
    Virology. 2003 May 25;310(1):8-15 PMID: 12788625
  26. Pandemic influenza and the global vaccine supply.
    Clin Infect Dis. 2003 Jun 15;36(12):1552-61 PMID: 12802755
  27. Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics.
    Virology. 2003 Sep 30;314(2):580-90 PMID: 14554086
  28. Report on avian influenza in the Eastern Hemisphere during 1997-2002.
    Avian Dis. 2003;47(3 Suppl):792-7 PMID: 14575066
  29. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block.
    J Virol. 1993 Sep;67(9):5585-94 PMID: 7688826
  30. Host cell proteases controlling virus pathogenicity.
    Trends Microbiol. 1994 Feb;2(2):39-43 PMID: 8162439
  31. Potential for transmission of avian influenza viruses to pigs.
    J Gen Virol. 1994 Sep;75 ( Pt 9):2183-8 PMID: 8077918
  32. Disease outbreaks in pigs in Great Britain due to an influenza A virus of H1N2 subtype.
    Vet Rec. 1995 Apr 1;136(13):328-9 PMID: 7541591
  33. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.
    Virology. 1995 Oct 1;212(2):323-30 PMID: 7571401
  34. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis.
    J Infect Dis. 1995 Nov;172(5):1352-5 PMID: 7594676
  35. Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en.
    Virology. 1995 Dec 20;214(2):475-84 PMID: 8553549
  36. Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en.
    Virology. 1995 Dec 20;214(2):642-6 PMID: 8553569
  37. Continued evolution of H1N1 and H3N2 influenza viruses in pigs in Italy.
    Virology. 1997 Jun 9;232(2):310-8 PMID: 9191844
  38. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness.
    Science. 1998 Jan 16;279(5349):393-6 PMID: 9430591
  39. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.
    Lancet. 1998 Feb 14;351(9101):467-71 PMID: 9482437
  40. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus.
    Lancet. 1998 Feb 14;351(9101):472-7 PMID: 9482438
  41. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.
    Antimicrob Agents Chemother. 1998 Mar;42(3):640-6 PMID: 9517945
  42. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
    Antiviral Res. 1998 Feb;37(2):107-20 PMID: 9588843
  43. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential.
    J Virol. 1998 Sep;72(9):7367-73 PMID: 9696833
  44. Laboratory containment for influenza A H5N1 virus: level 2, level 3, or level 3+?
    Commun Dis Public Health. 1998 Mar;1(1):71-2 PMID: 9718852
  45. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation.
    Cell. 1998 Oct 30;95(3):409-17 PMID: 9814710
  46. Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice.
    J Infect Dis. 1998 Dec;178(6):1592-6 PMID: 9815209
  47. Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.
    Antimicrob Agents Chemother. 1998 Dec;42(12):3234-41 PMID: 9835519
  48. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong.
    Virology. 1998 Dec 20;252(2):331-42 PMID: 9878612
  49. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties.
    J Virol. 1999 Feb;73(2):1146-55 PMID: 9882316
  50. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong.
    J Virol. 1999 Apr;73(4):3184-9 PMID: 10074171
  51. Role of hemagglutinin cleavage for the pathogenicity of influenza virus.
    Virology. 1999 May 25;258(1):1-20 PMID: 10329563
  52. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans.
    J Virol. 1999 Jul;73(7):5903-11 PMID: 10364342
  53. Generation of influenza A viruses entirely from cloned cDNAs.
    Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50 PMID: 10430945
  54. Genetic reassortment of avian, swine, and human influenza A viruses in American pigs.
    J Virol. 1999 Oct;73(10):8851-6 PMID: 10482643
  55. Human infection with influenza H9N2.
    Lancet. 1999 Sep 11;354(9182):916-7 PMID: 10489954
  56. Rescue of influenza A virus from recombinant DNA.
    J Virol. 1999 Nov;73(11):9679-82 PMID: 10516084
  57. Genetic characterization of H1N2 influenza A viruses isolated from pigs throughout the United States.
    J Clin Microbiol. 2002 Mar;40(3):1073-9 PMID: 11880444
  58. Pathogenesis of avian influenza A (H5N1) viruses in ferrets.
    J Virol. 2002 May;76(9):4420-9 PMID: 11932409
  59. Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses.
    Microbes Infect. 2002 May;4(6):647-55 PMID: 12048034
  60. Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR.
    Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8950-5 PMID: 12077307
  61. Avian influenza in Hong Kong 1997-2002.
    Avian Dis. 2003;47(3 Suppl):832-8 PMID: 14575073
  62. Update on molecular epidemiology of H1, H5, and H7 influenza virus infections in poultry in North America.
    Avian Dis. 2003;47(3 Suppl):888-97 PMID: 14575082
  63. Are we ready for pandemic influenza?
    Science. 2003 Nov 28;302(5650):1519-22 PMID: 14645836
  64. Wet markets--a continuing source of severe acute respiratory syndrome and influenza?
    Lancet. 2004 Jan 17;363(9404):234-6 PMID: 14738798
  65. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome.
    Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1356-61 PMID: 14745020
  66. Re-emergence of fatal human influenza A subtype H5N1 disease.
    Lancet. 2004 Feb 21;363(9409):617-9 PMID: 14987888
  67. PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice.
    Virology. 2004 Mar 15;320(2):258-66 PMID: 15016548
  68. Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks.
    J Virol. 2004 May;78(9):4892-901 PMID: 15078970
  69. Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia.
    Virology. 2000 Feb 15;267(2):279-88 PMID: 10662623
  70. Influenza virus neuraminidase inhibitors.
    Lancet. 2000 Mar 4;355(9206):827-35 PMID: 10711940
  71. The epidemiology and evolution of influenza viruses in pigs.
    Vet Microbiol. 2000 May 22;74(1-2):29-46 PMID: 10799776
  72. Emergence of H3N2 reassortant influenza A viruses in North American pigs.
    Vet Microbiol. 2000 May 22;74(1-2):47-58 PMID: 10799777
  73. A DNA transfection system for generation of influenza A virus from eight plasmids.
    Proc Natl Acad Sci U S A. 2000 May 23;97(11):6108-13 PMID: 10801978
  74. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans.
    J Virol. 2000 Jul;74(13):6105-16 PMID: 10846094
  75. Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans.
    J Virol. 2000 Jul;74(14):6592-9 PMID: 10864673
  76. Resistance of influenza viruses to neuraminidase inhibitors--a review.
    Antiviral Res. 2000 Jul;47(1):1-17 PMID: 10930642
  77. Genetic characterization of H3N2 influenza viruses isolated from pigs in North America, 1977-1999: evidence for wholly human and reassortant virus genotypes.
    Virus Res. 2000 Jun;68(1):71-85 PMID: 10930664
  78. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates.
    Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9654-8 PMID: 10920197
  79. Evolution of swine H3N2 influenza viruses in the United States.
    J Virol. 2000 Sep;74(18):8243-51 PMID: 10954521
  80. Molecular correlates of influenza A H5N1 virus pathogenesis in mice.
    J Virol. 2000 Nov;74(22):10807-10 PMID: 11044127
  81. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses.
    Antiviral Res. 2000 Nov;48(2):101-15 PMID: 11114412
  82. Pathology of fatal human infection associated with avian influenza A H5N1 virus.
    J Med Virol. 2001 Mar;63(3):242-6 PMID: 11170064
  83. Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses.
    Virology. 2001 Jan 20;279(2):375-84 PMID: 11162793
  84. Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets.
    J Virol. 2001 Mar;75(6):2516-25 PMID: 11222674
  85. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes.
    Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2746-51 PMID: 11226311
  86. H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity.
    Virology. 2001 Mar 15;281(2):156-62 PMID: 11277689
  87. Isolation of amantadine-resistant influenza a viruses (H3N2) from patients following administration of amantadine in Japan.
    J Clin Microbiol. 2001 Apr;39(4):1652-3 PMID: 11283109
  88. Managing influenza: amantadine, rimantadine and beyond.
    Int J Clin Pract. 2001 Apr;55(3):189-95 PMID: 11351773
  89. Pathogenesis of influenza A (H5N1) virus infection in a primate model.
    J Virol. 2001 Jul;75(14):6687-91 PMID: 11413336
  90. Ferrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virus.
    J Infect Dis. 2001 Sep 1;184(5):542-6 PMID: 11494159
  91. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses.
    Science. 2001 Sep 7;293(5536):1840-2 PMID: 11546875
  92. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.
    Antimicrob Agents Chemother. 2001 Oct;45(10):2723-32 PMID: 11557461
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
DOI
10.1128/JVI.78.17.8951-8959.2004
Published
2004-09-00
Pages
8951-9
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC506949
Subset
IM
Grants
Wellcome Trust · United Kingdom
NIAID NIH HHS · N01AI95357 · United States
NCI NIH HHS · P30 CA021765 · United States
NCI NIH HHS · CA-21765 · United States
External Links
PubMed source DOI: 10.1128/JVI.78.17.8951-8959.2004 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2